Alerts
Other content recommended for you
- CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications
- Risk of Parkinson’s disease in multiple sclerosis and neuromyelitis optica spectrum disorder: a nationwide cohort study in South Korea
- Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients
- Sera from neuromyelitis optica patients disrupt the blood–brain barrier
- ABN joint annual meeting 2009 with the Spanish Society of Neurology
- CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica
- A new locus for recessive distal spinal muscular atrophy at Xq13.1–q21
- Neurofilament light chain as a biomarker in neurological disorders
- Comparison of macular structural and vascular changes in neuromyelitis optica spectrum disorder and primary open angle glaucoma: a cross-sectional study
- Clinical features of neuromyelitis optica in a large Japanese cohort: comparison between phenotypes